Achieving Diagnostic Excellence in Prenatal Diagnosis Through Patient-Reported Measures; Comment on “Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens”

Articles in Press

Document Type : Commentary

Authors

1 School of Public Health, Zhejiang Chinese Medical University, Zhejiang, China

2 Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland

3 Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland

4 Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland

Abstract

McDonald and colleagues’ work “Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens” emphasizes the critical role of patient-reported measures (PRMs) in achieving diagnostic excellence, with a focus on equity. PRMs capture patients’ experiences, symptoms, and concerns throughout the diagnostic process, enhancing accuracy and addressing uncertainties. In contexts like maternity care, PRMs have been applied to reveal and reduce communication gaps and alleviate anxiety, offering crucial support for improving diagnostic experiences and outcomes. This commentary explores the application of McDonald and colleagues’ visions and roadmaps to prenatal diagnosis, specifically focusing “prenatal screening and testing” (PreST), a complex process where diverse patient populations face challenges in understanding and responding to sequential test results. Tailored diagnosis-related PRMs can provide healthcare providers with tools to enhance shared decision-making, equitable communication, and patient satisfaction, leading to more inclusive and personalized diagnostic pathways. 

Keywords

References

  1. McDonald KM, Gleason KT, Jajodia A, Haskell H, Dukhanin V. Achieving diagnostic excellence: roadmaps to develop and use patient-reported measures with an equity lens. Int J Health Policy Manag. 2024;13:8048. doi:34172/ijhpm.8048
  2. Dukhanin V, Gamper MJ, Gleason KT, McDonald KM. Patient-reported outcome and experience domains for diagnostic excellence: a scoping review to inform future measure development. Qual Life Res. 2024;33(11):2883-2897. doi:1007/s11136-024-03709-w
  3. Chen A. Understanding Patient Choice: A Study of Women’s Choice in Prenatal Screening and Testing. Espoo, Finland: Department of Industrial Engineering and Management, Aalto University; 2017.
  4. Kelly K, Leitao S, Meaney S, O'Donoghue K. Pregnant people's views and knowledge on prenatal screening for fetal trisomy in the absence of a national screening program. J Genet Couns. 2024;33(4):805-814. doi:1002/jgc4.1769
  5. Thorsen MM, Khanuja K, Mahoney RC, Al-Kouatly HB, Russo ML. Knowledge gaps and confidence in counseling about aneuploidy screening and testing: a survey of prenatal care clinicians. Prenat Diagn. 2024;44(3):297-303. doi:1002/pd.6524
  6. Chen A, Tenhunen H, Torkki P, et al. Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies. BMC Pregnancy Childbirth. 2018;18(1):119. doi:1186/s12884-018-1752-y
  7. Chen A, Tenhunen H, Torkki P, Heinonen S, Lillrank P, Stefanovic V. Women's decisional conflict in the pathway of prenatal screening and testing: an explorative study within Finnish public maternity care. J Perinat Med. 2020;48(6):527-537. doi:1515/jpm-2019-0450
  8. Chen A, Lillrank PM, Tenhunen H, et al. Context-based patient choice management in healthcare. Int J Health Care Qual Assur. 2018;31(1):52-68. doi:1108/ijhcqa-01-2017-0016
International Journal of Health Policy and Management

Articles in Press, Corrected Proof
Available Online from 16 June 2025

Files

History

  • Received Date: 25 November 2024
  • Revised Date: 13 June 2025
  • Accepted Date: 15 June 2025
  • First Published Date: 16 June 2025

Share

How to cite

Statistics